48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
The data should be submitted by August 12th 2021
Arch Pharma Labs has filed the application
The govt has rolled out three schemes for promoting the manufacture of API
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
Subscribe To Our Newsletter & Stay Updated
